Pharmaceuticals News and Research

RSS

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

Bacillus anthracis bacteria have very efficient machinery for injecting toxic proteins into cells, leading to the potentially deadly infection known as anthrax. A team of MIT researchers has now hijacked that delivery system for a different purpose: administering cancer drugs.

26 Sep 2014

Abbott acquires CFR Pharmaceuticals; declares results of tender offer for CFR's ordinary shares

Abbott has acquired control of CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding the company's presence in fast-growing markets.

26 Sep 2014

AcelRx plans for resubmission of Zalviso NDA

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today provided an update on the plans for the resubmission of the Company's New Drug Application (NDA) for Zalviso (sufentanil sublingual tablet system).

26 Sep 2014

International organizations join forces to develop inhaled form of oxytocin for postpartum hemorrhage

An international group of public and private organizations is collaborating to accelerate development of an innovative heat-stable and low-cost inhaled form of oxytocin to manage postpartum hemorrhage in resource-poor settings.

26 Sep 2014

CDC forecast: Ebola epidemic could infect more than 1.4 million people by January end

The Ebola epidemic could claim hundreds of thousands of lives and infect more than 1.4 million people by the end of January, according to a statistical forecast released this week by the U.S. Centers for Disease Control and Prevention.

26 Sep 2014

Drug firms shift sales calls from doctors to administrators controlling hospital formularies

Since many hospitals now work to help keep costs down by watching what drugs are used, pharmaceutical representatives must include administrators in their sales pitches. Also in the news, new concerns about the government's plan to open a database next week on drug makers' payments to doctors.

26 Sep 2014

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

IGI Laboratories, Inc., a New Jersey based specialty generic pharmaceutical company, today announced it has acquired the regulatory rights and related documents and records for 18 drug products from AstraZeneca, 17 of which were marketed.

25 Sep 2014

CorMedix submits IND application to FDA for Neutrolin

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, is pleased to announce that an Investigational New Drug application (IND) for Neutrolin was submitted to the United States Food and Drug Administration on Wednesday, September 24, 2014.

25 Sep 2014

NCCN ORP awards four research grants to advance development of nintedanib

The National Comprehensive Cancer Network Oncology Research Program has awarded four grants to investigators to evaluate and define the clinical effectiveness of the investigational compound nintedanib (BIBF 1120) in non-small cell lung, colorectal, and gastrointestinal cancers.

25 Sep 2014

Abbott announces expiration of the U.S. tender offer for CFR ordinary shares

Abbott today announced the expiration of the tender offer for the purchase from U.S. holders of the ordinary shares of CFR Pharmaceuticals S.A., a Chilean corporation, and for the purchase from all holders, wherever resident, of CFR's outstanding American Depositary Shares.

24 Sep 2014

Research report on biopharmaceutical and vaccine manufacturing markets

The total biopharmaceutical manufacturing market is growing, according to Kalorama Information's report, Biopharmaceutical and Vaccine Production Markets.

24 Sep 2014

Leading provider of eClinical solutions, epharmasolutions joins WIRB group of companies

WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies.

24 Sep 2014

Axio Research announces launch of Statistical Genetics and Genomics services

Axio Research announced today the launch of Statistical Genetics and Genomics services in response to the biopharmaceutical industry's need for advanced statistical support in the analysis and interpretation of complex genomic data for drug discovery and development, drug repositioning, and companion diagnostics development.

24 Sep 2014

Prioritizing scientific research to understand risks of PPCPs in the environment

In 2011 the Society of Environmental Toxicology and Chemistry held a workshop for 45 international experts to identify and prioritize the scientific research needed to understand the risks of pharmaceuticals and personal care products (PPCPs) in the environment.

24 Sep 2014

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Inovio Pharmaceuticals, Inc. announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc., an international DNA vaccine manufacturer in which Inovio holds a minority interest.

24 Sep 2014

Newborn screening can prevent lifelong disability

When your baby was born you likely heard a loud cry and examined your baby to make sure he/she had a full set of adorable fingers and toes. But just imagine a few days after you arrive home, your phone rings: your baby has screened positive for a genetic disorder.

24 Sep 2014

C Diff Foundation to present 2014 "Raising C.difficile Awareness" conference in November

C Diff Foundation is proud to present the 2014 "Raising C.difficile Awareness" conference. Join us November 4th at 8 a.m. – 5 p.m. at the University of Illinois at Chicago, Student Center, West 828 S. Wolcott Avenue, Thompson Room, Chicago, IL.

23 Sep 2014

KemPharm to initiate clinical trials in Canada for lead product candidate KP201

KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it received a No Objection Letter (NOL) from Health Canada to begin clinical trials in Canada for its lead product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen)

23 Sep 2014

Young scientists from European member country invited to apply for EFIC-Grünenthal Grant 2014

Young scientists from any European member country of the European Pain Federation EFIC® are invited to apply for the EFIC-Grünenthal Grant (E-G-G) 2014.

23 Sep 2014

MT Services reports Actos drug cases, updates settlement news

MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a primary focus on assisting plaintiffs of the after effects of the pharmaceutical drug Actos.

23 Sep 2014

Pharmaceuticals News and Research

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

Abbott acquires CFR Pharmaceuticals; declares results of tender offer for CFR's ordinary shares

AcelRx plans for resubmission of Zalviso NDA

International organizations join forces to develop inhaled form of oxytocin for postpartum hemorrhage

CDC forecast: Ebola epidemic could infect more than 1.4 million people by January end

Drug firms shift sales calls from doctors to administrators controlling hospital formularies

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

CorMedix submits IND application to FDA for Neutrolin

NCCN ORP awards four research grants to advance development of nintedanib

Abbott announces expiration of the U.S. tender offer for CFR ordinary shares

Research report on biopharmaceutical and vaccine manufacturing markets

Leading provider of eClinical solutions, epharmasolutions joins WIRB group of companies

Axio Research announces launch of Statistical Genetics and Genomics services

Prioritizing scientific research to understand risks of PPCPs in the environment

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Newborn screening can prevent lifelong disability

C Diff Foundation to present 2014 "Raising C.difficile Awareness" conference in November

KemPharm to initiate clinical trials in Canada for lead product candidate KP201

Young scientists from European member country invited to apply for EFIC-Grünenthal Grant 2014

MT Services reports Actos drug cases, updates settlement news

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence